Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
2.160
+1.150 (113.80%)
Aug 14, 2025, 9:29 AM - Market open
Trinity Biotech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 61.56 | 56.83 | 62.52 | 81.15 | 101.98 | Upgrade
|
| Revenue Growth (YoY) | 8.31% | -9.10% | -22.96% | -20.43% | 12.77% | Upgrade
|
| Cost of Revenue | 40.11 | 37.38 | 45.25 | 47.7 | 53.4 | Upgrade
|
| Gross Profit | 21.44 | 19.45 | 17.27 | 33.45 | 48.58 | Upgrade
|
| Selling, General & Admin | 28.82 | 31.15 | 26.98 | 22.5 | 25.07 | Upgrade
|
| Research & Development | 4.54 | 4.38 | 4.14 | 4.5 | 5.08 | Upgrade
|
| Other Operating Expenses | 1.79 | -0.14 | -0.34 | -0 | -0.02 | Upgrade
|
| Operating Expenses | 35.15 | 35.39 | 30.78 | 27 | 30.13 | Upgrade
|
| Operating Income | -13.7 | -15.94 | -13.51 | 6.46 | 18.45 | Upgrade
|
| Interest Expense | -11.91 | -10.15 | -11.53 | -7.09 | -5.54 | Upgrade
|
| Interest & Investment Income | - | 1.17 | - | 0 | 0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.17 | - | 0.23 | 1.22 | -1.22 | Upgrade
|
| EBT Excluding Unusual Items | -26.78 | -24.92 | -24.81 | 0.6 | 11.73 | Upgrade
|
| Merger & Restructuring Charges | -4.18 | - | - | - | -2.43 | Upgrade
|
| Impairment of Goodwill | -1.6 | -5.83 | - | -3.85 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.8 | -1.5 | - | - | - | Upgrade
|
| Asset Writedown | -0.61 | -3.77 | -5.36 | -2.51 | -17.22 | Upgrade
|
| Other Unusual Items | 1.64 | -0.91 | -13.61 | 3.84 | 1.28 | Upgrade
|
| Pretax Income | -30.73 | -36.93 | -43.78 | -1.92 | -6.63 | Upgrade
|
| Income Tax Expense | 0.49 | -0.06 | -0.19 | -0.07 | -0.62 | Upgrade
|
| Earnings From Continuing Operations | -31.22 | -36.87 | -43.59 | -1.85 | -6.01 | Upgrade
|
| Earnings From Discontinued Operations | -0.57 | 12.85 | 2.58 | 2.73 | -0.38 | Upgrade
|
| Net Income | -31.79 | -24.02 | -41.01 | 0.88 | -6.39 | Upgrade
|
| Net Income to Common | -31.79 | -24.02 | -41.01 | 0.88 | -6.39 | Upgrade
|
| Shares Outstanding (Basic) | 18 | 8 | 7 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 8 | 7 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | 134.62% | 13.46% | 61.40% | - | - | Upgrade
|
| EPS (Basic) | -1.77 | -3.14 | -6.08 | 0.21 | -1.53 | Upgrade
|
| EPS (Diluted) | -1.83 | -3.14 | -6.08 | 0.21 | -1.53 | Upgrade
|
| Free Cash Flow | -4.6 | -12.36 | -2.02 | 11.43 | 20.55 | Upgrade
|
| Free Cash Flow Per Share | -0.26 | -1.61 | -0.30 | 2.73 | 4.92 | Upgrade
|
| Gross Margin | 34.83% | 34.22% | 27.62% | 41.23% | 47.64% | Upgrade
|
| Operating Margin | -22.26% | -28.05% | -21.61% | 7.96% | 18.09% | Upgrade
|
| Profit Margin | -51.64% | -42.26% | -65.59% | 1.08% | -6.26% | Upgrade
|
| Free Cash Flow Margin | -7.47% | -21.75% | -3.23% | 14.08% | 20.15% | Upgrade
|
| EBITDA | -13.03 | -14.17 | -11.22 | 9.18 | 21.52 | Upgrade
|
| EBITDA Margin | -21.17% | -24.92% | -17.94% | 11.31% | 21.11% | Upgrade
|
| D&A For EBITDA | 0.68 | 1.78 | 2.29 | 2.72 | 3.08 | Upgrade
|
| EBIT | -13.7 | -15.94 | -13.51 | 6.46 | 18.45 | Upgrade
|
| EBIT Margin | -22.26% | -28.05% | -21.61% | 7.96% | 18.09% | Upgrade
|
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.